Dr Jeremy Teoh is currently the Assistant Dean (External Affairs) and Assistant Professor of the Faculty of Medicine, The Chinese University of Hong Kong. He has primary interests in bladder cancer and prostate cancer. For bladder cancer, he is leading a multi-centre randomized controlled trial on transurethral en bloc resection of bladder tumour. He has also developed a global consensus statement to standardize the en bloc resection approach. He is currently studying the urinary biomarkers, tumour heterogeneity and molecular classification of bladder cancer. For prostate cancer, he has published extensively on the adverse events related to androgen deprivation therapy. He has also helped conduct a clinical trial on the use of the da Vinci Single-Port Surgical System in radical prostatectomy. In 2021, he has been awarded the ‘Ten Outstanding Young Persons’ for his outstanding contributions in his profession.

Jeremy has received numerous research grants with a total funding of more than HKD 30 million. He has published more than 100 articles in peer-reviewed journals such as European Urology, Journal of Urology and BJU International. He has been a reviewer for more than 30 journals including Cochrane Urology, European Urology, and British Journal of Urology International. He is also serving as a member for several advisory boards for prostate cancer and bladder cancer. He is currently the Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong, Chair of the Young Fellows Chapter of the Hong Kong Academy of Medicine, and he has been the Director of the Lions Kidney Educational Centre & Research Foundation since 2016. He is also the founder of the UroSoMe (Urology Social Media) working group and he believes that social media plays an important role in the modern era of medicine.